Anika Therapeutics Inc ANIK

Healthcare Biotechnology

Anika Therapeutics, Inc. is a joint preservation company focused on developing, manufacturing, and commercializing products based on hyaluronic acid (HA) technology platform. The OA Pain Management product family consists of Monovisc and Orthovisc that provides pain relief from osteoarthritis conditions and Cingal consisting of its cross-linked HA material combined with a fast-acting steroid. Its Joint Preservation and Restoration product family consists of its portfolio of orthopedic regenerative solutions products: Integrity, Tactoset, and Hyalofast; its line of sports medicine solutions repairs and reconstructs damaged ligaments and tendons, and its Arthrosurface portfolio of bone preserving joint technologies, including partial joint replacement, joint resurfacing, and minimally invasive and bone sparing implants. Its Non-Orthopedic product family provides orthopedic applications, including adhesion barrier product, advanced wound care products, and ear, nose and throat products.

NDAQ:ANIK - Post by User

Anika Therapeutics Inc

Bullboard Posts

Post by Fugativeon Oct 17, 1999 11:44pm

259 Views

Post# 1031592

Self Funded through cash flow

The strongest feature the company has to offer is that it has been funded from its base of operations that have brought a solid cash flow for a few years now. The largest problem with the company is that is may be a little too technical for small investors. It will succeed from its Institutional buying.

Bullboard Posts

Hempalta acquires controlling interest in Hemp Carbon Standard